Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,687 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 634
Recruiting: 364
Ph III recruiting: 20
Growth YoY: −14.6%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 101–150 of 783 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07428993	Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma	recruiting	Phase 2	41	St. Jude Children's Research HospitalOTHER	1	Sep 1, 2026	clinicaltrials
NCT06515860	Neurofibromatosis Type 1 Tumor Early Detection Study(NF1-TED)	enrolling by invitation	—	1,000	David MillerOTHER	1	Aug 31, 2026